SEC Form 4 insider trading filings tracked in real time from EDGAR

Eastling Thomas Wilson — Chief Financial Officer

Insider trading activity for Eastling Thomas Wilson sourced from SEC EDGAR Form 4 filings.

Overview

  • Title: Chief Financial Officer
  • Company: GYRE THERAPEUTICS, INC.
  • Total insider trades: 7
  • Total buy volume: $0
  • Total sell volume: $0
  • Last trade: May 6, 2026

Recent Trades

DateInsiderTicker / Company TypeSharesValue
May 4, 2026 Eastling Thomas Wilson GYRE GYRE THERAPEUTICS, INC. BUY 33,271 N/A
May 4, 2026 Eastling Thomas Wilson GYRE GYRE THERAPEUTICS, INC. BUY 92,683 N/A
May 4, 2026 Eastling Thomas Wilson GYRE GYRE THERAPEUTICS, INC. BUY 95,060 N/A
May 4, 2026 Eastling Thomas Wilson GYRE GYRE THERAPEUTICS, INC. BUY 33,271 N/A
May 4, 2026 Eastling Thomas Wilson GYRE GYRE THERAPEUTICS, INC. BUY 11,882 N/A
May 4, 2026 Eastling Thomas Wilson GYRE GYRE THERAPEUTICS, INC. BUY 47,530 N/A
May 4, 2026 Eastling Thomas Wilson GYRE GYRE THERAPEUTICS, INC. BUY 95,060 N/A

← All executives · Full trades feed